The Centers for Disease Control and Prevention recently reported several cases of locally acquired malaria in Florida and Texas—the first such cases in the U.S. in over two decades. Manoj Duraisingh explains the significance of the cases and…
The wide-ranging health impacts of climate change, including food insecurity, migration, war, and the spread of infectious diseases—and practical solutions to address these problems—were the focus of a half-day symposium hosted by Harvard Chan School.
A range of topics regarding health care in Africa—including mental health, malaria, financing, and vaccine research, development, and manufacturing—were examined at the first-ever Africa Health Conference at Harvard Chan School.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.
Public health leaders from around the world gathered at Harvard University for a week-long course to learn the latest developments from experts and discuss new strategies for eradicating malaria.
Russia’s invasion of Ukraine has prompted a massive humanitarian crisis, with mounting military and civilian casualties and more than two million people on the move to escape the violence. In this Big 3 Q&A, Michael VanRooyen, director of…
Updates on vaccines for malaria and HPV, tampons as a human right, how other countries see American health care, and more.
Marcia Castro of Harvard Chan School has been named a Fellow of the American Association for the Advancement of Science.
In October, the World Health Organization (WHO) for the first time recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa.
The long and at times faltering fight against malaria hit a turning point this week when the World Health Organization (WHO) recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally…